Evidence map›Paper›PMID 34901101›Full record

ReviewFrontiers in nutrition2021

Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence.

Christopher Haskins, Justin Cohen, Rupesh Kotecha, Adeel Kaiser

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Energy metabolism in health and diseases.Signal transduction and targeted therapy · 2025
    Review
  3. Review
  4. Article
  5. Targeting Energy Metabolism in Cancer Treatment.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Christopher HaskinsDepartment of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD, United States.
Justin CohenDepartment of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD, United States.
Rupesh KotechaMiami Cancer Institute, Baptist Health, Miami, FL, United States.
Adeel KaiserDepartment of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD, United States.
Florida International University · USUniversity of Maryland, Baltimore · USUniversity of Maryland Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low carbohydrate diets have a promising mechanistic rationale in the treatment of cancer with favorable preclinical data. The strongest data suggest synergistic effects of dietary interventions with traditional cancer therapies. Recent prospective clinical trials suggest that low carbohydrate diets are safely and feasibly added within a busy oncology clinic, with hopeful additive effects in treatment enhancement.

Indexed as

cancercarbohydrate restrictionchemotherapyimmunotherapyketogenic diet (KD)metabolismradiation

Identifiers

PMID34901101
PMCPMC8655114
OpenAlexW3216278534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.